C3 glomerulopathy: Consensus report

Matthew C. Pickering; Vivette D. D'agati; Carla M. Nester; Richard J. Smith; Mark Haas; Gerald B. Appel; Charles E. Alpers; Ingeborg M. Bajema; Camille Bedrosian; Michael Braun; Mittie Doyle; Fadi Fakhouri; Fernando C. Fervenza; Agnes B. Fogo; Véronique Frémeaux-Bacchi; Daniel P. Gale; Elena Goicoechea De Jorge; Gene Griffin; Claire L. Harris; V. Michael Holers; Sally Johnson; Peter J. Lavin; Nicholas Medjeral-Thomas; B. Paul Morgan; Cynthia C. Nast; Laure Hélène Noel; D. Keith Peters; Santiago Rodríguez De Córdoba; Aude Servais; Sanjeev Sethi; Wen Chao Song; Paul Tamburini; Joshua M. Thurman; Michael Zavros; H. Terence Cook

doi:10.1038/ki.2013.377

C3 glomerulopathy: Consensus report

Matthew C. Pickering, Vivette D. D'agati, Carla M. Nester, Richard J. Smith, Mark Haas, Gerald B. Appel, Charles E. Alpers, Ingeborg M. Bajema, Camille Bedrosian, Michael Braun, Mittie Doyle, Fadi Fakhouri, Fernando C. Fervenza, Agnes B. Fogo, Véronique Frémeaux-Bacchi, Daniel P. Gale, Elena Goicoechea De Jorge, Gene Griffin, Claire L. Harris, V. Michael HolersSally Johnson, Peter J. Lavin, Nicholas Medjeral-Thomas, B. Paul Morgan, Cynthia C. Nast, Laure Hélène Noel, D. Keith Peters, Santiago Rodríguez De Córdoba, Aude Servais, Sanjeev Sethi, Wen Chao Song, Paul Tamburini, Joshua M. Thurman, Michael Zavros, H. Terence Cook

Research output: Contribution to journal › Article

283 Scopus citations

Abstract

C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.

Original language	English (US)
Pages (from-to)	1079-1089
Number of pages	11
Journal	Kidney international
Volume	84
Issue number	6
DOIs	https://doi.org/10.1038/ki.2013.377
State	Published - Dec 2013

Keywords

clinical immunology
clinical nephrology
complement
glomerulonephritis
immunology and pathology

ASJC Scopus subject areas

Nephrology

Access to Document

10.1038/ki.2013.377

Fingerprint Dive into the research topics of 'C3 glomerulopathy: Consensus report'. Together they form a unique fingerprint.

Cite this

Pickering, M. C., D'agati, V. D., Nester, C. M., Smith, R. J., Haas, M., Appel, G. B., Alpers, C. E., Bajema, I. M., Bedrosian, C., Braun, M., Doyle, M., Fakhouri, F., Fervenza, F. C., Fogo, A. B., Frémeaux-Bacchi, V., Gale, D. P., Goicoechea De Jorge, E., Griffin, G., Harris, C. L., ... Cook, H. T. (2013). C3 glomerulopathy: Consensus report. Kidney international, 84(6), 1079-1089. https://doi.org/10.1038/ki.2013.377

C3 glomerulopathy : Consensus report. / Pickering, Matthew C.; D'agati, Vivette D.; Nester, Carla M.; Smith, Richard J.; Haas, Mark; Appel, Gerald B.; Alpers, Charles E.; Bajema, Ingeborg M.; Bedrosian, Camille; Braun, Michael; Doyle, Mittie; Fakhouri, Fadi; Fervenza, Fernando C.; Fogo, Agnes B.; Frémeaux-Bacchi, Véronique; Gale, Daniel P.; Goicoechea De Jorge, Elena; Griffin, Gene; Harris, Claire L.; Holers, V. Michael; Johnson, Sally; Lavin, Peter J.; Medjeral-Thomas, Nicholas; Paul Morgan, B.; Nast, Cynthia C.; Noel, Laure Hélène; Peters, D. Keith; Rodríguez De Córdoba, Santiago; Servais, Aude; Sethi, Sanjeev; Song, Wen Chao; Tamburini, Paul; Thurman, Joshua M.; Zavros, Michael; Cook, H. Terence.

In: Kidney international, Vol. 84, No. 6, 12.2013, p. 1079-1089.

Research output: Contribution to journal › Article

Pickering, MC, D'agati, VD, Nester, CM, Smith, RJ, Haas, M, Appel, GB, Alpers, CE, Bajema, IM, Bedrosian, C, Braun, M, Doyle, M, Fakhouri, F, Fervenza, FC, Fogo, AB, Frémeaux-Bacchi, V, Gale, DP, Goicoechea De Jorge, E, Griffin, G, Harris, CL, Holers, VM, Johnson, S, Lavin, PJ, Medjeral-Thomas, N, Paul Morgan, B, Nast, CC, Noel, LH, Peters, DK, Rodríguez De Córdoba, S, Servais, A, Sethi, S, Song, WC, Tamburini, P, Thurman, JM, Zavros, M & Cook, HT 2013, 'C3 glomerulopathy: Consensus report', Kidney international, vol. 84, no. 6, pp. 1079-1089. https://doi.org/10.1038/ki.2013.377

Pickering, Matthew C. ; D'agati, Vivette D. ; Nester, Carla M. ; Smith, Richard J. ; Haas, Mark ; Appel, Gerald B. ; Alpers, Charles E. ; Bajema, Ingeborg M. ; Bedrosian, Camille ; Braun, Michael ; Doyle, Mittie ; Fakhouri, Fadi ; Fervenza, Fernando C. ; Fogo, Agnes B. ; Frémeaux-Bacchi, Véronique ; Gale, Daniel P. ; Goicoechea De Jorge, Elena ; Griffin, Gene ; Harris, Claire L. ; Holers, V. Michael ; Johnson, Sally ; Lavin, Peter J. ; Medjeral-Thomas, Nicholas ; Paul Morgan, B. ; Nast, Cynthia C. ; Noel, Laure Hélène ; Peters, D. Keith ; Rodríguez De Córdoba, Santiago ; Servais, Aude ; Sethi, Sanjeev ; Song, Wen Chao ; Tamburini, Paul ; Thurman, Joshua M. ; Zavros, Michael ; Cook, H. Terence. / C3 glomerulopathy : Consensus report. In: Kidney international. 2013 ; Vol. 84, No. 6. pp. 1079-1089.

@article{5320567ccfcd419786411b156bf34e64,

title = "C3 glomerulopathy: Consensus report",

abstract = "C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.",

keywords = "clinical immunology, clinical nephrology, complement, glomerulonephritis, immunology and pathology",

author = "Pickering, {Matthew C.} and D'agati, {Vivette D.} and Nester, {Carla M.} and Smith, {Richard J.} and Mark Haas and Appel, {Gerald B.} and Alpers, {Charles E.} and Bajema, {Ingeborg M.} and Camille Bedrosian and Michael Braun and Mittie Doyle and Fadi Fakhouri and Fervenza, {Fernando C.} and Fogo, {Agnes B.} and V{\'e}ronique Fr{\'e}meaux-Bacchi and Gale, {Daniel P.} and {Goicoechea De Jorge}, Elena and Gene Griffin and Harris, {Claire L.} and Holers, {V. Michael} and Sally Johnson and Lavin, {Peter J.} and Nicholas Medjeral-Thomas and {Paul Morgan}, B. and Nast, {Cynthia C.} and Noel, {Laure H{\'e}l{\`e}ne} and Peters, {D. Keith} and {Rodr{\'i}guez De C{\'o}rdoba}, Santiago and Aude Servais and Sanjeev Sethi and Song, {Wen Chao} and Paul Tamburini and Thurman, {Joshua M.} and Michael Zavros and Cook, {H. Terence}",

year = "2013",

month = dec,

doi = "10.1038/ki.2013.377",

language = "English (US)",

volume = "84",

pages = "1079--1089",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - C3 glomerulopathy

T2 - Consensus report

AU - Pickering, Matthew C.

AU - D'agati, Vivette D.

AU - Nester, Carla M.

AU - Smith, Richard J.

AU - Haas, Mark

AU - Appel, Gerald B.

AU - Alpers, Charles E.

AU - Bajema, Ingeborg M.

AU - Bedrosian, Camille

AU - Braun, Michael

AU - Doyle, Mittie

AU - Fakhouri, Fadi

AU - Fervenza, Fernando C.

AU - Fogo, Agnes B.

AU - Frémeaux-Bacchi, Véronique

AU - Gale, Daniel P.

AU - Goicoechea De Jorge, Elena

AU - Griffin, Gene

AU - Harris, Claire L.

AU - Holers, V. Michael

AU - Johnson, Sally

AU - Lavin, Peter J.

AU - Medjeral-Thomas, Nicholas

AU - Paul Morgan, B.

AU - Nast, Cynthia C.

AU - Noel, Laure Hélène

AU - Peters, D. Keith

AU - Rodríguez De Córdoba, Santiago

AU - Servais, Aude

AU - Sethi, Sanjeev

AU - Song, Wen Chao

AU - Tamburini, Paul

AU - Thurman, Joshua M.

AU - Zavros, Michael

AU - Cook, H. Terence

PY - 2013/12

Y1 - 2013/12

N2 - C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.

AB - C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.

KW - clinical immunology

KW - clinical nephrology

KW - complement

KW - glomerulonephritis

KW - immunology and pathology

UR - http://www.scopus.com/inward/record.url?scp=84888641200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888641200&partnerID=8YFLogxK

U2 - 10.1038/ki.2013.377

DO - 10.1038/ki.2013.377

M3 - Article

C2 - 24172683

AN - SCOPUS:84888641200

VL - 84

SP - 1079

EP - 1089

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 6

ER -